Naruse, Katsuya <br/><br/>
Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder.  [electronic resource] 

 -  Oncology reports  Jun 2010 
 - 1577-83 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or_00000798  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Transitional Cell--metabolism<br/>Cyclooxygenase 2--metabolism<br/>Female<br/>Humans<br/>Immunoenzyme Techniques<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Staging<br/>Receptor, ErbB-2--metabolism<br/>Survival Rate<br/>Treatment Outcome<br/>Urinary Bladder Neoplasms--metabolism